464 related articles for article (PubMed ID: 20047148)
1. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
Neve EP; Ingelman-Sundberg M
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
[TBL] [Abstract][Full Text] [Related]
2. Influence of protein-protein interactions on the cellular localization of cytochrome P450.
Szczesna-Skorupa E; Kemper B
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):123-36. PubMed ID: 18248308
[TBL] [Abstract][Full Text] [Related]
3. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms regulating the mitochondrial targeting of microsomal cytochrome P450 enzymes.
Ahn T; Yun CH
Curr Drug Metab; 2010 Dec; 11(10):830-8. PubMed ID: 21208176
[TBL] [Abstract][Full Text] [Related]
5. Topology of catalytic portion of prostaglandin I(2) synthase: identification by molecular modeling-guided site-specific antibodies.
Lin YZ; Deng H; Ruan KH
Arch Biochem Biophys; 2000 Jul; 379(2):188-97. PubMed ID: 10898934
[TBL] [Abstract][Full Text] [Related]
6. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase D activity of cytochrome P450 in human liver endoplasmic reticulum.
Yun CH; Ahn T; Guengerich FP; Yamazaki H; Shimada T
Arch Biochem Biophys; 1999 Jul; 367(1):81-8. PubMed ID: 10375402
[TBL] [Abstract][Full Text] [Related]
8. Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
Kumar G; Lau H; Laskin O
Cancer Chemother Pharmacol; 2009 May; 63(6):1171-5. PubMed ID: 19030860
[TBL] [Abstract][Full Text] [Related]
9. The potential pharmacological and toxicological impact of P450 screening.
Riley RJ
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):45-54. PubMed ID: 11727322
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
11. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry.
Redlich G; Zanger UM; Riedmaier S; Bache N; Giessing AB; Eisenacher M; Stephan C; Meyer HE; Jensen ON; Marcus K
J Proteome Res; 2008 Nov; 7(11):4678-88. PubMed ID: 18828626
[TBL] [Abstract][Full Text] [Related]
12. Intracellular transport and localization of microsomal cytochrome P450.
Neve EP; Ingelman-Sundberg M
Anal Bioanal Chem; 2008 Nov; 392(6):1075-84. PubMed ID: 18537026
[TBL] [Abstract][Full Text] [Related]
13. Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.
Kotrbová V; Aimová D; Brezinová A; Janouchová K; Poljaková J; Frei E; Stiborová M
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():18-22. PubMed ID: 17159771
[TBL] [Abstract][Full Text] [Related]
14. Topogenesis of a microsomal cytochrome P450 and induction of endoplasmic reticulum membrane proliferation in Saccharomyces cerevisiae.
Menzel R; Kärgel E; Vogel F; Böttcher C; Schunck WH
Arch Biochem Biophys; 1996 Jun; 330(1):97-109. PubMed ID: 8651709
[TBL] [Abstract][Full Text] [Related]
15. The role of microsomal cytochrome b5 in the metabolism of ethanol, drugs and the desaturation of fatty acids.
Ozols J
Ann Clin Res; 1976; 8 Suppl 17():182-92. PubMed ID: 12714
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical analysis of liver microsomal cytochromes P450 of the American alligator, Alligator mississippiensis.
Ertl RP; Bandiera SM; Buhler DR; Stegeman JJ; Winston GW
Toxicol Appl Pharmacol; 1999 Jun; 157(3):157-65. PubMed ID: 10373399
[TBL] [Abstract][Full Text] [Related]
17. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
Murray M
Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
Tang J; Amin Usmani K; Hodgson E; Rose RL
Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
[TBL] [Abstract][Full Text] [Related]
20. Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants.
Machala M; Soucek P; Neca J; Ulrich R; Lamka J; Szotáková B; Skálová L
Arch Toxicol; 2003 Oct; 77(10):555-60. PubMed ID: 14574442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
